Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes

Thomas Kocher; Patricia Peking; Alfred Klausegger; Eva Maria Murauer; JP Hofbauer; Verena Wally; Thomas Lettner; Stefan Hainzl; Michael Ablinger; Johann Bauer; Julia Reichelt; Ulrich Koller

Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes

Thomas Kocher, Patricia Peking, Alfred Klausegger, Eva Maria Murauer, JP Hofbauer, Verena Wally, Thomas Lettner, Stefan Hainzl, Michael Ablinger, Johann Bauer, Julia Reichelt, Ulrich Koller

Forschungsprogramm für Molekulare Therapie bei Genodermatosen
Universitätsklinik für Dermatologie und Allergologie
Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › publizierter Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	A57-A57
Fachzeitschrift	HUMAN GENE THERAPY
Jahrgang	28
Ausgabenummer	12
Publikationsstatus	Veröffentlicht - 2017
Veranstaltung	European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress - Berlin, GERMANY Dauer: 1 Jan. 2017 → …

Dieses zitieren

Kocher, T., Peking, P., Klausegger, A., Murauer, E. M., Hofbauer, JP., Wally, V., Lettner, T., Hainzl, S., Ablinger, M., Bauer, J., Reichelt, J., & Koller, U. (2017). Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes. HUMAN GENE THERAPY , 28(12), A57-A57.

Kocher, Thomas ; Peking, Patricia ; Klausegger, Alfred et al. / Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes. in: HUMAN GENE THERAPY 2017 ; Jahrgang 28, Nr. 12. S. A57-A57.

@article{32a3b3012261479d9ab95b018730bafa,

title = "Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes",

author = "Thomas Kocher and Patricia Peking and Alfred Klausegger and Murauer, {Eva Maria} and JP Hofbauer and Verena Wally and Thomas Lettner and Stefan Hainzl and Michael Ablinger and Johann Bauer and Julia Reichelt and Ulrich Koller",

year = "2017",

language = "English",

volume = "28",

pages = "A57--A57",

journal = "HUMAN GENE THERAPY ",

issn = "1043-0342",

number = "12",

note = "European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress ; Conference date: 01-01-2017",

}

Kocher, T , Peking, P , Klausegger, A, Murauer, EM, Hofbauer, JP, Wally, V, Lettner, T, Hainzl, S , Ablinger, M , Bauer, J, Reichelt, J & Koller, U 2017, 'Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes', HUMAN GENE THERAPY , Jg. 28, Nr. 12, S. A57-A57.

Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes. / Kocher, Thomas ; Peking, Patricia ; Klausegger, Alfred et al.
in: HUMAN GENE THERAPY , Jahrgang 28, Nr. 12, 2017, S. A57-A57.

Publikation: Beitrag in Fachzeitschrift › publizierter Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes

AU - Kocher, Thomas

AU - Peking, Patricia

AU - Klausegger, Alfred

AU - Murauer, Eva Maria

AU - Hofbauer, JP

AU - Wally, Verena

AU - Lettner, Thomas

AU - Hainzl, Stefan

AU - Ablinger, Michael

AU - Bauer, Johann

AU - Reichelt, Julia

AU - Koller, Ulrich

PY - 2017

Y1 - 2017

M3 - published Abstract (Journal)

SN - 1043-0342

VL - 28

SP - A57-A57

JO - HUMAN GENE THERAPY

JF - HUMAN GENE THERAPY

IS - 12

T2 - European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress

Y2 - 1 January 2017

ER -

Kocher T , Peking P , Klausegger A, Murauer EM, Hofbauer JP, Wally V et al. Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes. HUMAN GENE THERAPY . 2017;28(12):A57-A57.